Wednesday, November 6, 2019

Aurobindo Pharma gets 8 observations for 2 plants from USFDA

Aurobindo Pharma gets 8 observations for 2 plants from USFDA The USFDA inspected active pharmaceutical ingredients (API) manufacturing facility (Unit V) at Pashamylaram and API manufacturing facility (Unit VIII) at Gaddapotharam in Hyderabad between October 21 and October 28, the company said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2PSHuLM
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Market moves driven more by psychology than fundamentals: Samir Arora

Indian stock markets are caught between global worries and strong domestic company profits. Foreign investor activity, oil price swings, and...